Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for Uveitis Refractory to Cyclosporine A
NCT00803816Phase 2Completed
- Start
- Nov 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in Intermediate Uveitis (IU), Posterior Uveitis. Started Nov 2007; status: completed.
02
Drugs
everolimus
03
Conditions
Intermediate Uveitis (IU)Posterior Uveitis
Beyond the preview
Go deeper on NCT00803816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803816.